The Greater Cannabis Company, Inc. (GCAN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0001 (-25.00%)
Aug 1, 2025, 3:06 PM EDT

The Greater Cannabis Company Company Description

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics.

It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body.

The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders.

The company was founded in 2014 and is based in Baltimore, Maryland.

The Greater Cannabis Company, Inc.
The Greater Cannabis Company logo
CountryUnited States
Founded2014
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1
CEOAitan Zacharin

Contact Details

Address:
2833 Smith Avenue
Baltimore, Florida 21209
United States
Phone443 738 4051
Websitegcanrx.com

Stock Details

Ticker SymbolGCAN
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS3916571033
SIC Code2833

Key Executives

NamePosition
Aitan ZacharinChairman, President, Chief Executive Officer, Acting Chief Financial Officer and Treasurer
Motti StengeChief Operating Officer
Dr. Adi Aran M.D.Chief Scientific Advisor